Access to Advanced Health Institute (AAHI)
Wynton McClary, PhD, is a scientist specializing in product development and characterization, currently serving as Scientist II at The Access to Advanced Health Institute since April 2021. Previously, Wynton held the position of Scientist I at the same institution. Prior to this, Wynton was a postdoctoral fellow at the University of Colorado Anschutz Medical Campus, working in the lab of Dr. Carlos Catalano from October 2016 to March 2021. Wynton completed doctoral research at the University of Washington, focusing on lipid composition's effects on CYP3A4 dynamics and stability, and earned a PhD in Medicinal Chemistry with an emphasis on Biochemistry/Biophysics. Wynton's academic journey began with a B.S. in Biology Pre-Med from Eastern Washington University, followed by a role as a tutor in chemistry and life sciences.
Access to Advanced Health Institute (AAHI)
AAHI is a nonprofit biotech research institute located in Seattle, Washington that combines the high-quality science of an academic research organization with the product-development capabilities of a biotech company to help combat some of the world’s deadliest diseases, including COVID-19, cancer, fungal and parasitic infections, and other non-communicable diseases. For nearly three decades, AAHI, previously known as the Infectious Disease Research Institute, has focused on creating immune-enhancing technologies that improve the body’s natural response to disease. Through collaborations AAHI brings innovation from the lab to the clinic to the people, furthering AAHI’s mission to bring together the best experts, technologies, and platforms to create accessible, high-quality products and solutions. AAHI is working to build a world in which every person has access to tools that harness their immune system and allow them to live a healthy life free of illness and disease.